瞳孔计市场－2026-2031年预测

预计瞳孔计市场将从 2025 年的 530,398,000 美元成长到 2031 年的 779,397,000 美元，复合年增长率为 6.63%。

受神经系统疾病盛行率上升、技术创新和临床应用范围不断扩大的推动，瞳孔计市场正经历快速成长。由于磁振造影（MRI）和电脑断层扫描（CT）等影像方式已证实脑部活动与瞳孔扩张之间存在直接关联，因此，测量瞳孔扩张的瞳孔测量法对于理解各种潜在疾病的价值日益凸显。这种诊断方法有助于更深入地了解认知过程，并提供有关正常眼功能和受疾病影响的脑部活动的见解。泛自闭症障碍、帕金森氏症、忧郁症和焦虑症患者对刺激表现出异常的瞳孔测量反应。这拓宽了该技术的临床效用，使其可用于多种神经和精神疾病的诊断。

主要市场驱动因素

神经系统疾病的负担

全球非传染性神经系统疾病负担日益加重，主要原因是人口老化。神经系统疾病的主要病因包括癫痫、头痛和中风。瞳孔计透过测量眼球曲率来识别神经系统疾病，随着患者群体的不断扩大，对这类设备的需求也在增长。预计未来神经系统疾病患者人数将持续增加，医疗保健系统需要更先进的诊断工具来满足不断增长的患者群体的需求，因此，在预测期内，瞳孔计市场预计将保持持续增长。

政府和组织倡议

众多政府机构和私人组织正致力于提高人们对神经系统疾病的认识，并改善医疗服务的可近性。国际神经调控学会（International Society for Neuromodulation）是一家致力于推动神经调控科学发展的非营利组织，它透过会议、同行评审出版物、教育材料和线上平台传播讯息，促进神经调控技术的广泛应用。这些提高公众意识的努力以及医疗服务可近性的改善，正在帮助扩大瞳孔计市场，因为越来越多的医护人员和患者认识到客观神经系统评估的价值。

携带式瞳孔计的普及

预计在预测期内，携带式瞳孔计将实现最快的成长。携带式瞳孔计能够快速、准确地撷取瞳孔影像，用于诊断包括阿兹海默症在内的神经系统疾病。携带式的便利性和行动性正在推动其发展和应用范围的不断扩大。 NeurOptics是一家领先的携带式瞳孔计製造商，其产品广泛应用于重症监护和临床研究领域。此外，Adaptica等公司正在开发混合型便携式设备，例如整合了瞳孔测量功能的2WIN，展现了在外形和功能整合的创新。

视讯瞳孔计技术

视讯瞳孔仪可以记录瞳孔扩张的整个过程，有助于了解瞳孔变化及其根本原因。 NeuroOptics 是一家专注于瞳孔测量科学的公司，运用最尖端科技帮助医生提升患者照护品质。该公司已开发出多种用于重症监护和临床研究的视讯瞳孔仪。 NPi-200 重症监护视讯瞳孔仪配备红外线相机、中央处理器、精密光学元件和 LED 光源。其视讯功能可以记录瞳孔大小和反应随时间的变化，提供静态测量无法获得的动态数据。

技术进步

技术进步大大提高了瞳孔计的精度、效用和操作便利性。传统的瞳孔计使用可见光测量瞳孔反应，而红外线瞳孔测量已成为现代设备的标准配置。红外线测量具有高精度和高可靠性，尤其是在各种光照条件下，并且消除了传统测量中常见的环境因素干扰。

现代瞳孔计配备了高解析度相机和尖端成像技术，能够捕捉到清晰、细緻的瞳孔照片。此外，人工智慧演算法的开发和应用也进一步提升了诊断能力。人工智慧的整合实现了更精细的模式识别，能够识别出人眼难以察觉的细微瞳孔反应异常，从而提高诊断的灵敏度和特异性。

区域趋势

在北美市场主导地位

由于神经系统疾病发病率上升和视力相关问题日益增多，北美占据了瞳孔计市场的大部分份额。瞳孔计在美国各种医疗环境中的广泛应用预计将推动市场份额的成长。美国领先的NeuroOptics等主要企业正在开发先进的瞳孔计以提高诊断准确性。为了将市场拓展到传统神经系统应用之外，各公司正在探索瞳孔计在各种重症监护领域的潜在应用，并致力于将产品用途扩展到其他医疗领域。

亚太地区成长潜力

预计亚太地区在预测期内将展现出显着的成长潜力。透过各种线上市场和供应商增加瞳孔计的获取途径，有望推动区域市场的扩张。 NeurOptics、强生视力保健和Konan Medical等主要国际製造商均透过其区域子公司销售瞳孔计。 NeurOptics透过合作伙伴公司进行销售，例如印度的Hansraj Nayyar Medical India、日本的IMI Corporation和韩国的Neuroplus。 NIDEK等国际公司正在提高该地区瞳孔计的可及性和可用性，以支持这个高成长地区的市场发展。

战略产业方法

瞳孔仪市场的参与企业积极参与行业展会、展览和会议，以提高人们对检测法的认知度并展示其产品线。业内相关人员正在开发携带式设备，以克服移动性方面的挑战，并提高设备在各种情况下的易用性。各公司正在开发可安装在行动装置上的尖端软体，以实现远端瞳孔测量，从而扩大其可及性并实现即时医疗应用。

近期进展包括：2022年12月，NeuroOptics的神经瞳孔指数和自动瞳孔测量技术被纳入修订后的欧洲復苏委员会（ERC）和欧洲重症监护医学会（ESICM）復苏后护理指南，作为支持心臟骤心臟麻痹患者神经系统预后的客观检测法。 2022年5月，NeuroOptics开始在包括英国、法国、义大利、爱尔兰、澳洲和纽西兰在内的15个国家销售NPi-300瞳孔计。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 瞳孔计市场：依类型划分

• 介绍
• 影片
• 数位的

第六章 瞳孔计市场：移动性别

• 介绍
• 桌面型
• 携带式的

第七章 瞳孔计市场：依应用领域划分

• 介绍
• 眼科
• 神经科
• 肿瘤学
• 其他的

第八章 瞳孔计市场：依地区划分

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• NeurOptics, Inc.
• Adaptica
• Essilor Instruments USA
• Haag-Streit Group
• Johnson & Johnson Vision
• Visionix
• NIDEK CO., LTD.
• Reichert Technologies
• SCHWIND eye-tech-solutions
• US Ophthalmi

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

The pupillometer market is anticipated to grow at a 6.63% CAGR, reaching USD 779.397 million in 2031 from USD 530.398 million in 2025.

The pupillometer market is experiencing rapid growth driven by rising neurological disorder prevalence, technological innovation, and expanding clinical applications. Pupillometry-the measurement of pupil dilation to understand various underlying diseases-has become increasingly valuable as imaging modalities including MRI and CT have demonstrated direct correlations between brain activity and pupil dilation. This diagnostic approach aids deeper understanding of cognitive processes and provides insights into both normal eye functionality and illness-affected brain activity. Individuals with autism spectrum disorder, Parkinson's disease, depression, and anxiety display aberrant pupillometry responses to stimuli, expanding the technology's clinical utility across diverse neurological and psychiatric conditions.

Primary Market Drivers

Neurological Disorder Burden

The global burden of non-communicable neurological illnesses is rising, primarily driven by aging populations. Principal causes of neurological illnesses include epilepsy, headache conditions, and stroke. Pupillometers measure eye curvature to identify neurological problems, creating rising demand for these instruments as patient populations expand. The anticipated growth in persons affected by neurological illnesses positions the pupillometer market for sustained development throughout the projected period, as healthcare systems require increasingly sophisticated diagnostic tools for growing patient populations.

Government and Organizational Initiatives

Numerous governmental and commercial organizations are working to increase understanding of neurological illnesses and enhance healthcare access. The International Neuromodulation Society, a non-profit organization devoted to advancing neuromodulation science, disseminates information and encourages neuromodulation through conferences, peer-reviewed publications, educational material, and online platforms. These awareness campaigns and healthcare access advancements drive pupillometer market expansion by creating more informed healthcare providers and patients who understand the value of objective neurological assessment.

Hand-Held Pupillometer Adoption

Hand-held pupillometers are anticipated to develop at the quickest rate during the projected period. Portable pupillometers enable users to quickly and precisely capture pupil images for diagnosing neurological conditions including Alzheimer's disease. The hand-held format's convenience and mobility are driving increased development and popularity. NeurOptics represents a leading manufacturer of handheld pupillometers for critical care and practical research applications. Additionally, companies like Adaptica have developed hybrid hand-held devices such as 2WIN that incorporate pupillometry functionality, demonstrating innovation in form factor and feature integration.

Video Pupillometer Technology

Video pupillometers enable recording of complete pupil dilation processes, facilitating understanding of variations and their underlying causes. NeurOptics, specializing in pupillometry science, employs cutting-edge technology enabling physicians to deliver improved patient care. The company has developed various video pupillometers for critical care and practical research. The NPi-200 video pupillometer for critical care features infrared cameras, CPUs, highly accurate optics, and LED light sources. Video functionality aids documenting how pupil size and response vary over time, providing temporal data unavailable through static measurements.

Technological Advancement

Technological improvements have substantially enhanced pupillometer accuracy, usefulness, and usability. While traditional pupillometers measured pupillary responses using visible light, infrared pupillometry has become the standard in contemporary devices. Infrared light provides greater precision and dependability, particularly under diverse lighting situations, eliminating environmental variables that previously complicated measurements.

Modern pupillometers incorporate high-resolution cameras with cutting-edge imaging capabilities to capture accurate, detailed pupil photographs. Additionally, artificial intelligence algorithms are being developed and implemented to enhance diagnostic capabilities. AI integration enables more sophisticated pattern recognition, potentially identifying subtle pupillary response abnormalities that might escape human observation, expanding diagnostic sensitivity and specificity.

Regional Dynamics

North American Market Leadership

North America holds the majority of pupillometer market share due to rising neurological illness frequency and vision-related issues. Acceptance and installation of pupillometers across diverse U.S. settings is anticipated to fuel market share growth. Major industry companies like NeurOptics, headquartered in the United States, are developing sophisticated pupillometers for improved diagnosis. Companies are investigating pupillometer applications in various critical care domains to broaden product utility for additional medical problems, expanding the addressable market beyond traditional neurological applications.

Asia Pacific Growth Potential

The Asia Pacific region is anticipated to demonstrate major growth potential during the projected period. Expanding pupillometer access through various online marketplaces and providers is expected to support regional market expansion. Major international manufacturers including NeurOptics, Johnson & Johnson Vision, and Konan Medical offer pupillometers through regional subsidiaries. NeurOptics distributes through partners in India, Japan, and South Korea-Hansraj Nayyar Medical India, IMI Co., and Neuroplus. International players like NIDEK have improved regional pupillometer access and availability, supporting market development in this high-growth region.

Strategic Industry Approaches

Pupillometer market participants engage in trade events, exhibits, and conferences to raise knowledge of pupillometry and showcase product ranges. Industry players develop portable devices addressing mobility concerns and improving device usability across varied contexts. Companies have developed cutting-edge software installable on mobile devices to complete pupillometry processes remotely, expanding accessibility and enabling point-of-care applications.

Recent developments include December 2022 incorporation of NeurOptics' Neurological Pupil Index and automated pupillometry into updated European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care as objective measurements supporting neurological prognosis in cardiac arrest patients. In May 2022, NeurOptics launched the NPi-300 pupillometer across 15 nations including the United Kingdom, France, Italy, Ireland, Australia, and New Zealand.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Pupillometer Market Segmentation

• By Type
• Video
• Digital
• By Mobility
• Table-top
• Hand-held
• By Application
• Ophthalmology
• Neurology
• Oncology
• Others
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PUPILLOMETER MARKET BY TYPE

• 5.1. Introduction
• 5.2. Video
• 5.3. Digital

6. PUPILLOMETER MARKET BY MOBILITY

• 6.1. Introduction
• 6.2. Table-top
• 6.3. Hand-held

7. PUPILLOMETER MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Ophthalmology
• 7.3. Neurology
• 7.4. Oncology
• 7.5. Others

8. PUPILLOMETER MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. NeurOptics, Inc.
• 10.2. Adaptica
• 10.3. Essilor Instruments USA
• 10.4. Haag-Streit Group
• 10.5. Johnson & Johnson Vision
• 10.6. Visionix
• 10.7. NIDEK CO., LTD.
• 10.8. Reichert Technologies
• 10.9. SCHWIND eye-tech-solutions
• 10.10. US Ophthalmi

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations